Scientists retrospectively analyzed the clinical, histopathological, and molecular data of 3,254 Chinese patients with preinvasive lesions (n = 252), minimally invasive adenocarcinomas (n = 479), and invasive lung adenocarcinoma (n = 2,523). Molecular data were elucidated using a targeted 68-gene next-generation sequencing panel.
[Modern Pathology]